Publication:
Response to brentuximab vedotin in advanced stage MF/Sezary syndrome with low CD-30 expression: real-life data of the German Cutaneous Lymphoma Network

Research Projects

Organizational Units

Journal Issue

Abstract

Description

Keywords

Citation

Collections

Endorsement

Review

Supplemented By

Referenced By